Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.

Clinical trial NCT01707745 · UNKNOWN

Trial details

NCT number: NCT01707745
Sponsor: Sivakami A Pai
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Stage 2+ or Stage 3+ Retinopathy of Prematurity in Zone I or Zone II.

Start date: 2010-01-01
Primary completion: 2012-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.